BDB564182

CD85k Mouse anti-Human, Alexa Fluor 647, Clone: ZM3.8, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB564182-Each-of-1 In Stock ₹ 28,791.50

BDB564182 - Each of 1

₹ 28,791.50

In Stock

Quantity

1

Base Price: ₹ 28,791.50

GST (18%): ₹ 5,182.47

Total Price: ₹ 33,973.97

Antigen

CD85k

Classification

Monoclonal

Conjugate

Alexa Fluor 647

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human

Isotype

IgG1

Applications

Flow Cytometry

Clone

ZM3.8

Description

LILRB4; ILT-3; HM18; LIRB4; LILRB5; LIR-5

Immunogen

Human ILT3 Recombinant Protein

Quantity

100 Tests

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Related Products

Img

BD Biosciences

BDB564345

--

Img

BD Biosciences

BDB564344

--

Img

BD Biosciences

BDB564091

--

Img

BD Biosciences

BDB564254

--

Img

BD Biosciences

BDB564409

--

Img

BD Biosciences

BDB564184

--

Img

BD Biosciences

BDB564191

--

Img

BD Biosciences

BDB564114

--

Description

  • The ZM3.8 monoclonal antibody specifically binds to CD85k which is also known as Immunoglobulin-like transcript 3 (ILT-3) and Monocyte inhibitory receptor HM18
  • CD85k is encoded by LILRB4 (Leukocyte immunoglobulin-like receptor, subfamily B member 4) and is expressed as a type I transmembrane glycoprotein
  • CD85k is comprised of two C2-type Ig domains, a transmembrane region, and a cytoplasmic tail with three immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
  • CD85k is selectively expressed by myeloid antigen presenting cells including monocytes, macrophages, and dendritic cells
  • CD85k functions as an inhibitory receptor
  • ILT3 can also function in antigen capture and presentation
  • It is efficiently internalized upon cross-linking, and delivers its ligand to an intracellular compartment where it is processed and ultimately presented by APCs to T cells
  • Thus, ILT3 is a novel inhibitory receptor that can negatively regulate activation of APCs and can be used by APCs for antigen uptake
  • ILT3 expression is upregulated on tolerogenic dendritic cells that can induce regulatory T cells.